Driptane

Medicinal product

(Invented) name

Driptane

Active substance (s)

Oksibutinino hidrochloridas

Strength

5 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G04BD04, Oxybutynin

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2021-08-05

Date of renewal

Documents

1567_Driptane_2024-05-14_K.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

tabletėje yra	1 vnt.
Oksibutinino hidrochloridas	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
107078	93181	1093181	lizdinė plokštelė	N60		Receptinis	LT/L/21/1567/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2021-08-05	Registruotas